SCNI
Scinai Immunotherapeutics Ltd.
$0.4080
-0.97%
$1.4M
No data for this timeframe.
Vol
Market Cap$1.4M
Cap SizeNano Cap
Inst. Holders1 funds
Inst. Value$41.00
Inst. Activity0 buys / 1 sells
Reddit Sentiment67° Warm
SEC Reports5
Exchange Nasdaq·Sector Biological Products, (No Diagnostic Substances)·Inc. L3·CIK 0001611747·Prev Close $0.4120
Recent Activity
Jun 8, 2026
SEC
Scinai filed a 6-K correcting a clerical error in its May 12 proxy statement regarding Chairman Mark Germain's service a
6-K — Impact 2/10
May 20, 2026
SEC
Scinai Immunotherapeutics' shelf registration on Form F-3 (File No. 333-295698) was declared effective by the SEC on May
EFFECT — Impact 6/10
May 8, 2026
SEC
Scinai Immunotherapeutics filed audited FY2025 financials for its newly acquired CDMO subsidiary, Scinai Biopharma Servi
6-K — Impact 7/10
Inst.
MORGAN STANLEY — NEAR_EXIT
58 shares ($41.00)
Inst.
UBS Group AG — NEAR_EXIT
8 shares ($10.00)
Apr 27, 2026
short_interest
FTD: SCNI — 1,113,017 shares ($0.8M) failed to deliver
Settlement: 20260427, Price: $0.74, FTD Value: $823,632.58, SCINAI IMMUNOTHERAPEUTICS LTD
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
6-K
2/10
Scinai filed a 6-K correcting a clerical error in its May 12 proxy statement regarding Chairman Mark Germain's service a
Jun 8, 2026
BEARISH
EFFECT
6/10
Scinai Immunotherapeutics' shelf registration on Form F-3 (File No. 333-295698) was declared effective by the SEC on May
May 20, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| MORGAN STANLEY | $41.00 | NEAR_EXIT |
Reddit Sentiment
67°
Warm
Bearish
Neutral
Bullish
1 institutional holders with $41.00 total value (58 shares) as of 2025-Q4. Top holders: MORGAN. Net selling activity: 1 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 58 | $41.00 | 100.0% | NEAR_EXIT -76.3% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | NEAR_EXIT | 245 | 58 | -76.3% | $41.00 | 2025-Q4 |
| UBS Group AG | NEAR_EXIT | 12,056 | 8 | -99.9% | $10.00 | 2025-Q3 |
| UBS Group AG | TRIM | 23,488 | 14,932 | -36.4% | $40.2K | 2025-Q1 |
| UBS Group AG | DOUBLED | 30 | 23,488 | +78193.3% | $78.6K | 2024-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
5 SEC filing reports analyzed. Sentiment: 0 bullish, 4 bearish, 0 mixed, 1 neutral. Avg impact: 5.8/10.
NEUTRAL
6-K
2/10
Scinai filed a 6-K correcting a clerical error in its May 12 proxy statement regarding Chairman Mark
Jun 8, 2026
BEARISH
EFFECT
6/10
Scinai Immunotherapeutics' shelf registration on Form F-3 (File No. 333-295698) was declared effecti
May 20, 2026
BEARISH
6-K
7/10
Scinai Immunotherapeutics filed audited FY2025 financials for its newly acquired CDMO subsidiary, Sc
May 8, 2026
BEARISH
6-K
7/10
Scinai Immunotherapeutics is raising capital through a PIPE offering of ADSs at $0.48 per share with
Apr 27, 2026
BEARISH
20-F
7/10
Scinai Immunotherapeutics' 20-F filing reveals a company in transition, shifting from a struggling b
Apr 1, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2024-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2024-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Aug 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jul 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jun 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% | |
| May 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
67°
Warm
Bearish
Neutral
Bullish
2 mentions
2 bullish
0 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Apr 25, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 24, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
Apr 27, 2026
short_interest
FTD: SCNI — 1,113,017 shares ($0.8M) failed to deliver
Settlement: 20260427, Price: $0.74, FTD Value: $823,632.58, SCINAI IMMUNOTHERAPEUTICS LTD
Apr 24, 2026
short_volume
Short Volume: SCNI — 55.3% short (51.7M / 93.4M)
Short: 51,664,316 | Exempt: 8,788,652 | TRF Vol: 93,353,064 | Short Ratio: 55.3% | Off-exchange volume (dark pool + OTC)